We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$256M
AUM Growth
+$22.2M
Cap. Flow
+$15.1M
Cap. Flow %
5.91%
Top 10 Hldgs %
26.1%
Holding
284
New
33
Increased
92
Reduced
102
Closed
31

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$5.43M
2
ED icon
Consolidated Edison
ED
+$4.83M
3
KR icon
Kroger
KR
+$3.65M
4
EXC icon
Exelon
EXC
+$3.63M
5
AMT icon
American Tower
AMT
+$3.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$4.55M
2
MCK icon
McKesson
MCK
+$2.28M
3
NTNX icon
Nutanix
NTNX
+$1.86M
4
NVDA icon
NVIDIA
NVDA
+$1.79M
5
AKAM icon
Akamai
AKAM
+$1.62M

Sector Composition

Rank Sector Weight
1 Healthcare 21.98%
2 Consumer Staples 20.68%
3 Communication Services 14.33%
4 Financials 11.35%
5 Technology 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCI icon
51
Service Corp International
SCI
$11.4B
$1.46M 0.57%
17,915
+13,976
+355% +$1.09M
MOH icon
52
Molina Healthcare
MOH
$10.3B
$1.45M 0.57%
4,863
+1,120
+30% +$352K
FTNT icon
53
Fortinet
FTNT
$112B
$1.39M 0.54%
13,122
-13,438
-51% -$1.36M
MELI icon
54
Mercado Libre
MELI
$91.3B
$1.31M 0.51%
502
+106
+27% +$248K
AKAM icon
55
Akamai
AKAM
$16.8B
$1.28M 0.5%
16,071
-20,916
-57% -$1.62M
INCY icon
56
Incyte
INCY
$23.5B
$1.24M 0.48%
18,238
+10,205
+127% +$647K
NBIX icon
57
Neurocrine Biosciences
NBIX
$17.7B
$1.21M 0.47%
9,584
-12,428
-56% -$1.43M
IBN icon
58
ICICI Bank
IBN
$106B
$1.15M 0.45%
34,192
+4,412
+15% +$146K
CAG icon
59
Conagra Brands
CAG
$7.07B
$1.11M 0.43%
+54,081
New +$1.27M
TSN icon
60
Tyson Foods
TSN
$20.2B
$1.07M 0.42%
19,077
-5,980
-24% -$344K
RDDT icon
61
Reddit
RDDT
$32.5B
$1.04M 0.41%
+6,942
New +$787K
SNAP icon
62
Snap
SNAP
$7.32B
$1.01M 0.39%
116,036
-85,693
-42% -$711K
LULU icon
63
lululemon athletica
LULU
$13B
$1M 0.39%
+4,231
New +$1.17M
HRL icon
64
Hormel Foods
HRL
$13.9B
$949K 0.37%
31,364
-8,027
-20% -$242K
NTNX icon
65
Nutanix
NTNX
$14.9B
$890K 0.35%
11,640
-25,821
-69% -$1.86M
PGR icon
66
Progressive
PGR
$124B
$850K 0.33%
3,187
-4,567
-59% -$1.25M
V icon
67
Visa
V
$677B
$819K 0.32%
2,307
+450
+24% +$157K
CAH icon
68
Cardinal Health
CAH
$53.4B
$814K 0.32%
4,845
-4,088
-46% -$607K
UTHR icon
69
United Therapeutics
UTHR
$26.3B
$774K 0.3%
2,693
-3,695
-58% -$1.1M
MSFT icon
70
Microsoft
MSFT
$2.84T
$768K 0.3%
1,544
-179
-10% -$77.7K
SRPT icon
71
Sarepta Therapeutics
SRPT
$1.66B
$767K 0.3%
44,861
+7,053
+19% +$301K
NTRS icon
72
Northern Trust
NTRS
$22.2B
$752K 0.29%
5,928
+759
+15% +$77.6K
WT icon
73
WisdomTree
WT
$2.97B
$715K 0.28%
62,150
+7,059
+13% +$66.1K
PFE icon
74
Pfizer
PFE
$140B
$700K 0.27%
28,898
-37,857
-57% -$883K
XYZ
75
Block Inc
XYZ
$45.9B
$694K 0.27%
10,217
+2,487
+32% +$145K
1 2
3
4 5

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2025 Portfolio in Review

As of Q2 2025, TOBAM held 284 positions worth $256M, up 9.5% from $234M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM deployed $15.1M of net new capital in Q2 2025, opening 33 new positions and adding to 92 existing holdings. Its largest new stake was D.R. Horton: 15,865 shares worth $2.04M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Consumer Staples and Communication Services.

On the sell side, the largest reduction was AbbVie, an estimated $4.55M trimmed.

  • TOBAM's largest Q2 2025 buy was D.R. Horton: 15,865 shares worth $2.04M.
  • TOBAM added most to UnitedHealth in Q2 2025, an estimated $5.43M increase.
  • TOBAM's biggest Q2 2025 reduction was AbbVie, cutting an estimated $4.55M.
  • TOBAM fully exited International Flavors & Fragrances in Q2 2025, selling an estimated $775K.
  • TOBAM's ten largest holdings make up 26% of its $256M portfolio in Q2 2025.
  • TOBAM opened 33 new positions and closed 31 in Q2 2025.
  • TOBAM's portfolio value rose 9.5% quarter-over-quarter to $256M.

Based on TOBAM's 13F filing for Q2 2025, filed 8 Aug 2025.